NMT Medical Hopes To Avoid Another Headache In Modified Migraine Trial
This article was originally published in The Gray Sheet
Executive Summary
NMT Medical will move forward with its planned PFO closure migraine study under a new trial design cleared recently by FDA, the firm announced Aug. 31